Pasithea Therapeutics Corp. (KTTA)
0.5731
-0.01
(-1.26%)
USD |
NASDAQ |
Sep 04, 12:26
Pasithea Therapeutics Total Liabilities (Quarterly) : 1.870M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.870M |
| March 31, 2026 | 1.542M |
| December 31, 2025 | 5.021M |
| September 30, 2025 | 1.424M |
| June 30, 2025 | 1.831M |
| March 31, 2025 | 1.680M |
| December 31, 2024 | 1.282M |
| September 30, 2024 | 0.824M |
| June 30, 2024 | 1.488M |
| March 31, 2024 | 2.525M |
| December 31, 2023 | 2.718M |
| Date | Value |
|---|---|
| September 30, 2023 | 2.284M |
| June 30, 2023 | 2.559M |
| March 31, 2023 | 2.910M |
| December 31, 2022 | 2.682M |
| September 30, 2022 | 2.820M |
| June 30, 2022 | 1.554M |
| March 31, 2022 | 1.101M |
| December 31, 2021 | 1.900M |
| September 30, 2021 | 4.567M |
| June 30, 2021 | 0.4547M |
| March 31, 2021 | 0.2395M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.71M |
| Shareholders Equity (Quarterly) | 49.84M |
| Current Ratio | 26.25 |
| Net Debt Paydown Yield | 0.31% |